UNSPSC 51172307: Trientine

This classification denotes a metal chelator with the molecular formula C6H18N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SJ76Y07H5F, chemically known as 1,4,7,10-tetraazadecane but generally known as trientine, which bears US NIH Compound Identifier 5565. European Medicines Agency schedules Trientine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11281MIG. The term TRIENTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20).

UNSPSC 51172307 Trientine, a Commodity code, shows minimal relevance to recent state and local procurement activity. The code nominally refers to a specific pharmaceutical chelating agent, but the three recent opportunities identified under this code classification involve drug testing services, direct-to-manufacturer pharmaceutical procurement strategy, and generic multi-source pharmaceuticals and OTC products—none of which involve trientine procurement or use. The mismatch suggests either a data-tagging error in the source or that trientine procurement, if it occurs in state and local government, does not generate recent visible solicitation activity in the monitored opportunity stream.

The three identified opportunities span Texas state and local agencies and a multi-state cooperative purchasing vehicle. Collin County Community Supervision and Corrections Department issued RFP 2026-327 on July 9, 2026 (due July 23, 2026) for offender specimen collection and drug testing services, estimated at $600,000 over two years with three optional one-year renewals. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 as a market-intelligence solicitation on direct-to-manufacturer prescription programs, with no award value or formal evaluation criteria specified. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across member states and local facilities. No trientine-specific procurement is evident in any of these opportunities, and the code shows no decision-relevant activity for vendors seeking to supply the pharmaceutical named in the UNSPSC category.